Qnity Electronics supplies chemicals and materials to makes of semiconductors.
DuPont de Nemours (DD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DuPont de Nemours, Inc. (NYSE:DD ) Q2 2025 Earnings Call August 5, 2025 8:00 AM ET Company Participants Ann Giancristoforo - VP for Investor Relations Antonella B. Franzen - Senior VP & CFO Edward D.
The headline numbers for DuPont de Nemours (DD) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
DuPont (DD) shares rose Tuesday when the chemicals and materials manufacturer posted better-than-expected results and boosted its guidance on higher sales and volumes, plus a tax benefit. It also lowered its anticipated tariff hit.
DD's Q2 earnings and sales top estimates, fueled by volume growth in ElectronicsCo and IndustrialsCo segments.
DuPont de Nemours (DD) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.06 per share. This compares to earnings of $0.97 per share a year ago.
DuPont de Nemours (DD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DuPont's FilmTec Hypershell XP RO-8038 boosts dairy processing with up to 50% more productivity or 50% less energy use.
DuPont's Costa Rica expansion introduces sterile healthcare packaging, a first for the region's medical device industry.
Innovation, cost savings and healthcare acquisitions support DD as it navigates weak demand and hefty separation costs in 2025.